Expression of Ki-67 antigen and caspase-3 protein in benign lesions and esophageal carcinoma

Anticancer Research

Volumn 30, Issue 7, 2010, Pages 2845-2849

  Bellini, Marilanda Ferreira ^a   Cury, Patrícia Maluf ^b   Silva, Ana Elizabete ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

Author keywords

Chagasic megaesophagus; Chronic esophagitis; CPP32; Esophageal squamous cell carcinoma; Ki 67

Indexed keywords

CASPASE 3; KI 67 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER PATIENT; CELL PROLIFERATION; CHAGAS DISEASE; CHRONIC DISEASE; CONTROLLED STUDY; ESOPHAGITIS; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MALE; MEGAESOPHAGUS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; APOPTOSIS; CASPASE 3; CELL GROWTH PROCESSES; CHRONIC DISEASE; ESOPHAGEAL ACHALASIA; ESOPHAGITIS; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; SEX FACTORS; SMOKING;

EID: 77955784934     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Koch WM, Boyle JO, Mao L, Hankim J, Hruban RH and Sidransky D: TP53 gene mutations as markers of tumor spread in synchoronous oral cancer. Arch Otolaryngol Head Neck Surg 120: 943-947, 1994. (Pubitemid 24287709)
2. Cheng KC and Loeb LA: Genomic instability and tumor progression: mechanistic considerations. Adv Cancer Res 60: 121-156, 1993.
3. Nowell PC: Clonal evolution of tumor cell sub-populations. Science 194: 23, 1976.
4. Krajewska M, Wang HG, Krajewski S, Zapata JM, Shabaik A, Gascoyne R and Reed JC: Immunohistochemical analysis of in vivo patterns of expression of CPP32 (caspase-3), a cell death protease. Cancer Res 57(8): 1605-1613, 1997. (Pubitemid 27175582)
5. Hsia Jy, Chen Cy, Chen Jt, Hsu CP, Shai SE, Yang SS, Chuang CY, Wang PY and Miaw J: Prognostic significance of caspase-3 expression in primary resected esophageal squamous cell carcinoma. EJSO 29: 44-48, 2003.
6. Sutter AP, Maaser K, Höpfner M, Barthel B, Grabowski P, Faiss S, Carayon P, Zeitz M and Scherübl H: Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human esophageal cancer cells. Int J Cancer 102: 318-327, 2002.
7. Xue LY, Hu N, Song YM, Zou SM, Shou JZ, Qian LX, Ren LQ, Lin DM, Tong T, He ZG, Zhan QM, Taylor PR and Lu N: Tissue microarray analysis reveals a tight correlation between protein expression pattern and progression of esophageal squamous cell carcinoma. BMC Cancer 6: 296-311, 2006.
8. IHC World, [Internet]. Accessed on: November 25th, 2008: http://www.ihcworld.com/-protocols/antibody-protocols/ki67-no vocastra.htm
9. Mastracci L, Grillo F, Zentilin P, Spaggiari P, Dulbecco P, Pigozzi S, Savarino V and Fiocca R: Cell proliferation of squamous epithelium in gastro-oesophageal reflux disease: correlations with clinical, endoscopic and morphological data. Aliment Pharmacol Ther 25: 637-645, 2006. (Pubitemid 46255861)
10. Figueroa JD, Terry MB, Gammon MD, Vaughan TL, Risch HA, Zhang FF, Kleiner DE, Bennett WP, Howe CL, Dubrow R, Mayne ST, Fraumeni JF Jr. and Chow WH: Cigarette smoking, body mass index, gastro-esophageal reflux disease, and non- steroidal anti-inflammatory drug use and risk of subtypes of esophageal and gastric cancers by P53 overexpression. Cancer Causes Control 20(3): 361-368, 2009.
11. Zhang GH, Su M, Tian DP, Huang HH, Wu XY, Zheng RM and Li QS: Analysis of basement membrane structure and inflammation during the development of esophageal squamous cell carcinoma in the Chinese Chaoshan high-risk region. Cancer Invest 26(3): 296-305, 2008.
12. Beardsmore DM, Verbeke CS, Davies CL, Guillou PJ and Clark GW: Apoptotic and proliferative indexes in esophageal cancer: predictors of response to neoadjuvant therapy. J Gastrointest Surg 7(1): 77-86, 2003.
13. Muñoz N: Le déspistage du cancer de l'oesophage est-il réalisable? Semaines dès Hôpitaux de Paris 73: 633-635, 1997.
14. Mandard AM, Hainaut P and Hollstein M: Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutat Res 462: 335-342, 2000. (Pubitemid 30190239)
15. Miller RT, Immunohistochemistry in Urothelial Dysplasia. In: The Focus- Immunohistochemistry. ProPath [Internet]. Accessed on December 17th, 2008 http://www.ihcworld.com/ -newsletter/2003/focus-jun-2003.pdf, 2003.
16. Boone J, van Hillegersberg R, van Diest PJ, Offerhaus GJ, Rinkes IH and Kate FJ: Validation of tissue microarray technology in squamous cell carcinoma of the esophagus. Virchows Arch 452: 507-514, 2008.
17. Instat, GraphPad Instat.Instant biostatistic [Internet]. Accessed on April 3rd, 2007. http://www.graphpad.com/instat/instat.htm
18. Takeuchi H, Ozawa S, Ando N, Kitagawa Y, Ueda M and Kitajima M: Cell-cycle regulators and the Ki-67 labeling index can predict the response to chemoradiotherapy and the survival of patients with locally advanced squamous cell carcinoma of the esophagus. Ann Surg Oncol 10(7): 792-800, 2003.
19. Huang JX, Yan W, Song ZX, Qian RY, Chen P, Salminen E and Toppari J: Relationship between proliferative activity of cancer cells and clinicopathological factors in patients with esophageal squamous cell carcinoma. World J Gastroenterol 19: 2956-2959, 2005.
20. Horii N, Nishimura Y, Okuno Y, Kanamori S, Hiraoka M, Shimada Y and Imamura M: Impact of neoadjuvant chemotherapy on Ki-67 and PCNA labeling indices for esophageal squamous cell carcinoma. Int J Radiation Oncology Biol Phys 49(2): 527-532, 2001.
21. Youssef EM, Matsuda T, Takada N, Osugi H, Higashino M, Kinoshita H, Watanabe T, Katsura Y, Wanibuchi H and Fukushima S: Prognostic significance of the MIB-1 proliferation index for patients with squamous cell carcinoma of the esophagus. Cancer 76: 358-366, 1995.
22. Kawamura T, Goseki N, Koike M, Takizawa T and Endo M: Acceleration of proliferative activity of esophageal squamous cell carcinoma with invasion beyond the mucosa: Immunohistochemical analysis of Ki-67 and p53 antigen in relation to histopathological findings. Cancer 77: 843-849, 1996. (Pubitemid 26061275)
23. Ikeda G, Isaji S, Chandra B, Watanabe M and Kawarada Y: Prognostic significance of biologic factors in squamous cell carcinoma of the esophagus. Cancer 86(8): 1396-1405, 1999. (Pubitemid 29489770)
24. Shimada Y and Imamura M: Prognostic factors for esophageal cancer - from the viewpoint of molecular biology. Gan To Kagaku Ryoho 23(8): 972-981, 1996.
25. Kurabayashi A, Furihata M, Matsumoto M, Ohtsuki Y, Sasaguri S and Ogoshi S: Expression of Bax and apoptosis-related proteins in human esophageal squamous cell carcinoma including dysplasia. Mod Pathol 14(8): 741-747, 2001. (Pubitemid 33069831)
26. Chang MS, Lee HS, Lee BL, Kim YT, Lee JS and Kim WH: Differential protein expression between esophageal squamous cell carcinoma and dysplasia, and prognostic significance of protein markers. Pathol Res Pract 201(6): 417-425, 2005.